Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin Choy

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
Cancer|October 4, 2016
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumorScott M Schuetze, Vanessa Bolejack, Edwin Choy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2024
A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid HemangioendotheliomaScott M Schuetze, Karla V Ballman, Rachel Heise, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2026
A pooled analysis of phase 2 clinical trials in advanced chordomaGregory M Cote, Corrine F Elliott, Astrid Lipplaa, et al.
Life Science Alliance|December 28, 2020
The chromatin landscape of primary synovial sarcoma organoids is linked to specific epigenetic mechanisms and dependenciesGaylor Boulay, Luisa Cironi, Sara P Garcia, et al.
Nature Communications|April 28, 2022
EWSR1-ATF1 dependent 3D connectivity regulates oncogenic and differentiation programs in Clear Cell SarcomaEmely Möller, Viviane Praz, Sanalkumar Rajendran, et al.
Cell Reports|April 16, 2020
LIN28B Underlies the Pathogenesis of a Subclass of Ewing SarcomaTugba Keskin, Arnaud Bakaric, Patricia Waszyk, et al.
Cell Reports|April 3, 2020
LIN28B Underlies the Pathogenesis of a Subclass of Ewing Sarcoma LIN28B Control of EWS-FLI1 StabilityTugba Keskin, Arnaud Bakaric, Patricia Waszyk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2023
Outcomes After Preoperative Chemoradiation With or Without Pazopanib in Non-Rhabdomyosarcoma Soft Tissue Sarcoma: A Report From Children's Oncology Group and NRG OncologyAaron R Weiss, Yen-Lin Chen, Thomas J Scharschmidt, et al.
Lancet (London, England)|November 15, 2024
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trialYvonne M Mowery, Karla V Ballman, Angela M Hong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 7, 2020
NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021Margaret von Mehren, John M Kane, Marilyn M Bui, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Cancer|October 4, 2016
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumorScott M Schuetze, Vanessa Bolejack, Edwin Choy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2024
A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid HemangioendotheliomaScott M Schuetze, Karla V Ballman, Rachel Heise, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2026
A pooled analysis of phase 2 clinical trials in advanced chordomaGregory M Cote, Corrine F Elliott, Astrid Lipplaa, et al.
Life Science Alliance|December 28, 2020
The chromatin landscape of primary synovial sarcoma organoids is linked to specific epigenetic mechanisms and dependenciesGaylor Boulay, Luisa Cironi, Sara P Garcia, et al.
Nature Communications|April 28, 2022
EWSR1-ATF1 dependent 3D connectivity regulates oncogenic and differentiation programs in Clear Cell SarcomaEmely Möller, Viviane Praz, Sanalkumar Rajendran, et al.
Cell Reports|April 16, 2020
LIN28B Underlies the Pathogenesis of a Subclass of Ewing SarcomaTugba Keskin, Arnaud Bakaric, Patricia Waszyk, et al.
Cell Reports|April 3, 2020
LIN28B Underlies the Pathogenesis of a Subclass of Ewing Sarcoma LIN28B Control of EWS-FLI1 StabilityTugba Keskin, Arnaud Bakaric, Patricia Waszyk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2023
Outcomes After Preoperative Chemoradiation With or Without Pazopanib in Non-Rhabdomyosarcoma Soft Tissue Sarcoma: A Report From Children's Oncology Group and NRG OncologyAaron R Weiss, Yen-Lin Chen, Thomas J Scharschmidt, et al.
Lancet (London, England)|November 15, 2024
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trialYvonne M Mowery, Karla V Ballman, Angela M Hong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 7, 2020
NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021Margaret von Mehren, John M Kane, Marilyn M Bui, et al.
Pageof 18